Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05111223 · ClinicalTrials.gov registry record · NA

Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making

A NA study of Healthy, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05111223 is a NA study of Healthy that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 120 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05111223, a NA study of Healthy, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This research study examines the contribution of orbitofrontal cortex (OFC) networks to decision-making.

Conditions Studied

Interventions

  • DEVICE Real transcranial magnetic stimulation (TMS) before conditioning
  • DEVICE Real transcranial magnetic stimulation (TMS) before devaluation test
  • DEVICE Sham transcranial magnetic stimulation (TMS)

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-07-12
Est. Completion 2026-08-31
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05111223

The ClinicalTrials.gov registry entry for NCT05111223 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Real transcranial magnetic stimulation (TMS) before conditioning is the first listed.

NCT05111223 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05111223 about?

NCT05111223 is a clinical study titled "Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making". This research study examines the contribution of orbitofrontal cortex (OFC) networks to decision-making.

What is the current status of trial NCT05111223?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-07-12. Estimated completion is 2026-08-31.

What conditions does trial NCT05111223 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05111223?

The interventions under investigation include: Real transcranial magnetic stimulation (TMS) before conditioning (DEVICE), Real transcranial magnetic stimulation (TMS) before devaluation test (DEVICE), Sham transcranial magnetic stimulation (TMS) (DEVICE).

Who is sponsoring clinical trial NCT05111223?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05111223 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.